Jul. 14 at 10:56 PM
$IGC Captain “Sully” Sullenberger’s heartbreaking Alzheimer’s diagnosis is another reminder that this disease touches millions of families and highlights the urgent need for better treatments. While no one benefits from news like this, increased public awareness often drives greater attention, funding, and investor interest in companies developing Alzheimer’s therapies.
With IGC Pharma’s Phase 2 CALMA trial targeting Alzheimer’s-related agitation nearing a major readout, the spotlight on this disease could put IGC on more investors’ radar at a critical time. Awareness fuels urgency, and urgency can fuel innovation.
$MRNA $LLY $PFE
https://www.foxnews.com/health/miracle-hudson-hero-captain-sully-sullenberger-reveals-alzheimers-diagnosis
